Please login to the form below

Not currently logged in

Fresenius Kabi Oncology

This page shows the latest Fresenius Kabi Oncology news and features for those working in and with pharma, biotech and healthcare.

Two blood cancer drugs among CHMP recommendations

Two blood cancer drugs among CHMP recommendations

The CHMP also granted positive opinions to Fresenius' generic version of the chemotherapy busulfan and to a biosimilar version of Amgen's Neupogen to be marketed by Accord. ... The final recommendation was for a generic version of busulfan to be marketed

Latest news

  • GSK loses patent on Tykerb in India GSK loses patent on Tykerb in India

    A bid to overturn the patent - filed by New Delhi-based Fresenius Kabi Oncology Ltd - was upheld by India's Intellectual Property Appellate Board (IPAB) last week, opening the door to

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....